drugset / Trial / NCT03560583

Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients

NCT03560583

Recruiting 60 enrolled Barzilai Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

Poor ovarian response population of ART are considered the biggest challenge for providers. Hitherto, no one protocol has been proven to be effect in this subgroup of IVF patients. Metoclopramide belongs to the antiemetic group, used for motion sickness and during early gestation for hyperemesis gravidarum. The mechanism of action is antagonisim to dopamine receptors. We hypothesize than by blocking dopamine receptors and decreasing the dopaminergic tone there is a possibility to increase the sensitivity of ovarian response to gonadotropins during controlled ovarian stimulation and result in increased oocyte retrival.

Timeline

Start
2021-05-05
Primary completion
2027-12
Completion
2028-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 10 mg

Indications

No indication recorded.